The physicians at New Hampshire Oncology-Hematology offer a wide
array of opportunities for patients to participate in research. Most
often, they participate by taking part in clinical trials, which are
structured research experiments that explore promising new ways to
treat cancer. NHOH’s clinical research program is affiliated with
the Dana-Farber Cancer Institute and its Harvard Medical
School-affiliated research program.
